Dr Louise Schaper at PSA25[/caption]
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Q&A: ‘I’m going overseas tomorrow . . . can you witness...
While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...
Harnessing different abilities
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...
Medicine safety – a new national priority
A watershed moment for patients, pharmacists and medicine safety was reached last week when federal, state and territory health ministers declared Medicine Safety and...
Patients with COPD terrified of contracting COVID-19
After almost 2 years of the COVID-19 pandemic, pharmacists must emphasise the importance of maintaining lung health on World COPD Day (17 November).
Resistance movement: Pharmacy’s fight against antimicrobial resistance
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...
